Concepedia

Francheska Colón‐González

FC

Statistics

Publications

9

Citations

303

H-Index

9

Active since

2007

Affiliations

University of Pennsylvania(Current)

Thomas Jefferson University

Merck & Co., Inc., Rahway, NJ, USA (United States)

UConn Health

Translational Therapeutics (United States)

Francheska Colón‐González is an author at University of Pennsylvania specializing in signal transduction, cell signaling, and pharmacy.

Publications per year

2007–2020

9

Publications

9

Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin–GUCY2C Paracrine Signaling Axis

Jieru E. Lin, Francheska Colón‐González, Erik Blomain et al. · Cancer Research · 2016 · 59 citations · Full text

, , +16

Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants

Elizabeth G. Rhee, Matthew L. Rizk, Nicole Calder et al. · Antimicrobial Agents and Chemotherapy · 2018 · 57 citations · Full text

, , +12

Effect of Polymer Amphiphilicity on Loading of a Therapeutic Enzyme into Protective Filamentous and Spherical Polymer Nanocarriers

Eric Simone, Thomas D. Dziubla, Francheska Colón‐González et al. · Biomacromolecules · 2007 · 53 citations

, , +17

Atogepant Is Not Associated With Clinically Meaningful Alanine Aminotransferase Elevations in Healthy Adults

K. Chris Min, Walter K. Kraft, Phung Bondiskey et al. · Clinical and Translational Science · 2020 · 36 citations · Full text

, , +13

Identification of an Autoinhibitory Mechanism That Restricts C1 Domain-mediated Activation of the Rac-GAP α2-Chimaerin

Francheska Colón‐González, Federico Coluccio Leskow, Marcelo G. Kazanietz · Journal of Biological Chemistry · 2008 · 34 citations · Full text

, , +11

1–5 of 9